TIAA CREF INVESTMENT MANAGEMENT LLC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 223 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2019. The put-call ratio across all filers is 0.36 and the average weighting 0.3%.

Quarter-by-quarter ownership
TIAA CREF INVESTMENT MANAGEMENT LLC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q1 2019$7,514,000
+46.4%
93,861
-1.4%
0.01%
+25.0%
Q4 2018$5,134,000
-66.4%
95,239
-51.4%
0.00%
-20.0%
Q3 2018$15,294,000
+127.6%
195,922
+85.1%
0.01%0.0%
Q2 2018$6,720,000
-36.3%
105,853
-8.1%
0.01%
-28.6%
Q1 2018$10,557,000
+21.1%
115,122
-0.4%
0.01%
+16.7%
Q4 2017$8,720,000
+6.7%
115,631
-1.4%
0.01%0.0%
Q3 2017$8,172,000
+32.3%
117,296
-3.8%
0.01%
+50.0%
Q2 2017$6,179,000
+143.7%
121,941
+92.3%
0.00%
+100.0%
Q1 2017$2,536,000
+56.8%
63,428
+10.1%
0.00%
+100.0%
Q4 2016$1,617,000
-13.9%
57,633
-8.9%
0.00%0.0%
Q3 2016$1,878,000
+44.8%
63,229
-1.3%
0.00%0.0%
Q2 2016$1,297,000
+126.7%
64,067
+102.1%
0.00%
Q1 2016$572,000
-31.5%
31,7060.0%0.00%
-100.0%
Q4 2015$835,000
+23.3%
31,7060.0%0.00%0.0%
Q3 2015$677,000
-50.9%
31,706
-39.1%
0.00%0.0%
Q2 2015$1,379,00052,0660.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q2 2019
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 559,381$41,098,00015.69%
Casdin Capital, LLC 940,000$69,061,800,0007.15%
Ghost Tree Capital, LLC 325,000$23,878,0006.08%
CADIAN CAPITAL MANAGEMENT, LP 1,418,704$104,232,0004.96%
DAFNA Capital Management LLC 123,218$9,053,0003.40%
BVF INC/IL 437,565$32,148,0003.38%
Opaleye Management Inc. 105,000$7,714,0002.79%
Cormorant Asset Management, LP 493,000$36,221,0002.20%
Novo Holdings A/S 170,667$12,539,0002.15%
Artal Group S.A. 600,000$44,082,0001.77%
View complete list of BLUEPRINT MEDICINES CORP shareholders